The Chief Executive Officer of Johnson & Johnson (NYSE:JNJ), William Weldon intends to resign from his post in April. His decision follows a recent wave of recalls questioning over the quality of the healthcare company’s products.
Johnson & Johnson, the healthcare giant, reported on Tuesday that William Weldon, will retain the post of chairman. He had worked on both designations for about 10 years.
Furthermore Vice Chairman Alex Gorsky, 51 year old man, will serve on CEO position as of next coming board of directors meeting which will held on April 26 2012. Alex will be the ninth CEO to lead the company since J&J founded in 1886.
In William Weldon’s working period, the company extended an extensive business as compared to more than 250 companies, from prescription drugmakers to a medical devices division and units that make personal care products.
During the previous 02 years, the company that have a goodwill of high quality, has seen that its good reputation going to be negative as a recent wave of recalls questioning over the quality represented that the company had failed to fulfill the expectations.

Johnson & Johnson (NYSE:JNJ) witnessed volume of 8.08 million shares during last trade however it holds an average trading capacity of 10.00 million shares. JNJ shares opened at $65.23 reached intraday low of $64.75 and went +0.08% up to close at $65.04.

JNJ shares price distanced by -0.25% from 20 days average, +0.05% from SMA50 and +1.37% from SMA200. Similarly, the shares performance calculated for a week provided positive result of 0.56%, -0.35% for a month and Year-to-Date performance was -0.82%.

The company has an Enterprise Value of $165.14 billion where in most recent quarter it had a total cash in hand amounted to $30.93 billion with a 22.52 book value per share. The beta value of 0.54 signifies to the movement of price with the market condition. The percentage of holdings by the insider in JNJ is 0.03%.

The net profit margin in last 12 months grew up to 14.87%.

The Company in past 12 months achieved Gross Profit of $42.80 billion where the year to year quarterly revenue growth was 3.91% and Net Income Available to Shareholders reached to $9.67 billion with the diluted EPS of 3.49.